Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
96.72
-1.10 (-1.12%)
At close: Jun 30, 2025, 4:00 PM
96.72
0.00 (0.00%)
After-hours: Jun 30, 2025, 4:58 PM EDT
Revvity Market Cap
Revvity has a market cap or net worth of $11.40 billion as of June 30, 2025. Its market cap has decreased by -15.78% in one year.
Market Cap
11.40B
Enterprise Value
13.59B
1-Year Change
-15.78%
Ranking
Category
Stock Price
$96.72
Market Cap Chart
Since December 1, 1998, Revvity's market cap has increased from $1.28B to $11.40B, an increase of 788.78%. That is a compound annual growth rate of 8.56%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 27, 2025 | 11.53B | -15.12% |
Dec 31, 2024 | 13.58B | 0.69% |
Dec 29, 2023 | 13.49B | -23.84% |
Dec 30, 2022 | 17.71B | -30.20% |
Dec 31, 2021 | 25.37B | 57.91% |
Dec 31, 2020 | 16.07B | 48.95% |
Dec 31, 2019 | 10.79B | 23.46% |
Dec 31, 2018 | 8.74B | 8.41% |
Dec 29, 2017 | 8.06B | 41.08% |
Dec 30, 2016 | 5.71B | -4.73% |
Dec 31, 2015 | 6.00B | 21.39% |
Dec 31, 2014 | 4.94B | 6.60% |
Dec 31, 2013 | 4.63B | 27.20% |
Dec 31, 2012 | 3.64B | 61.08% |
Dec 30, 2011 | 2.26B | -25.79% |
Dec 31, 2010 | 3.05B | 26.77% |
Dec 31, 2009 | 2.40B | 46.34% |
Dec 31, 2008 | 1.64B | -46.73% |
Dec 31, 2007 | 3.08B | 12.83% |
Dec 29, 2006 | 2.73B | -11.29% |
Dec 30, 2005 | 3.08B | 6.97% |
Dec 31, 2004 | 2.88B | 33.04% |
Dec 31, 2003 | 2.17B | 107.75% |
Dec 31, 2002 | 1.04B | -70.73% |
Dec 31, 2001 | 3.56B | -32.07% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 696.15B |
Johnson & Johnson | 366.71B |
AbbVie | 322.03B |
Novo Nordisk | 304.96B |
UnitedHealth Group | 280.41B |
Novartis AG | 235.85B |
Abbott Laboratories | 233.80B |
AstraZeneca | 217.42B |